Literature DB >> 11495809

Varicella-zoster virus: molecular virology and virus-host interactions.

A M Arvin1.   

Abstract

Cosmid-based mutagenesis and methods to examine varicella-zoster virus (VZV) tropism for differentiated human cells in vivo provide new information about molecular mechanisms of VZV infection. How specific VZV gene products contribute to viral replication has been further defined, and effects of VZV on expression of cellular genes have been demonstrated.

Entities:  

Mesh：

Year:  2001        PMID： 11495809     DOI： 10.1016/s1369-5274(00)00233-2

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN： 1369-5274            Impact factor:   7.934


  15 in total

1.  Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3.

Authors:  Huifang Zhu; Chunfu Zheng; Junji Xing; Shuai Wang; Shuping Li; Rongtuan Lin; Karen L Mossman
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 2.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

3.  Aberrant virion assembly and limited glycoprotein C production in varicella-zoster virus-infected neurons.

Authors:  Charles Grose; Xiaoli Yu; Randall J Cohrs; John E Carpenter; Jacqueline L Bowlin; Don Gilden
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

Review 4.  Preventing varicella-zoster disease.

Authors:  Sophie Hambleton; Anne A Gershon
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.

Authors:  Jeremy O Jones; Marvin Sommer; Shaye Stamatis; Ann M Arvin
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion.

Authors:  Tadahiro Suenaga; Maki Matsumoto; Fuminori Arisawa; Masako Kohyama; Kouyuki Hirayasu; Yasuko Mori; Hisashi Arase
Journal:  J Biol Chem       Date:  2015-06-23       Impact factor: 5.157

7.  Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.

Authors:  Mark L Quinlivan; Anne A Gershon; Mahmoud M Al Bassam; Sharon P Steinberg; Philip LaRussa; Richard A Nichols; Judith Breuer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-20       Impact factor: 11.205

Review 8.  Varicella zoster virus vaccines: potential complications and possible improvements.

Authors:  Benjamin Silver; Hua Zhu
Journal:  Virol Sin       Date:  2014-10-24       Impact factor: 4.327

9.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.